Table 3 Complete antibiogram profile of MDR K. pneumoniae isolates, including disc concentrations and resistance distribution.
Class | Antibiotic | Disc concentration (μg) | MDR resistance % | Control resistance % |
|---|---|---|---|---|
Fluoroquinolones | Ciprofloxacin | 5 μg | 100% | 0% |
Fluoroquinolones | Levofloxacin | 5 μg | 97% | 0% |
Fluoroquinolones | Norfloxacin | 10 μg | 93% | 0% |
Aminoglycosides | Gentamicin | 10 μg | 100% | 0% |
Aminoglycosides | Tobramycin | 10 μg | 92% | 0% |
Aminoglycosides | Amikacin | 30 μg | 85% | 0% |
Cephalosporins (3rd gen) | Ceftriaxone | 30 μg | 90% | 0% |
Cephalosporins (3rd gen) | Ceftazidime | 30 μg | 88% | 0% |
Cephalosporins (3rd gen) | Cefotaxime | 30 μg | 91% | 0% |
Carbapenems | Imipenem | 10 μg | 20% | 0% |
Carbapenems | Meropenem | 10 μg | 20% | 0% |
β-lactam/β-lactamase inhibitor | Piperacillin–Tazobactam | 100/10 μg | 83% | 0% |
Folate pathway inhibitors | TMP–SMX | 1.25/23.75 μg | 100% | 0% |
Tetracyclines | Tetracycline | 30 μg | 100% | 0% |
